Syncom Formul.

{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "12.50",
    "chg": -0.09,
    "chgp": "-0.71%",
    "dir": -1,
    "prev_price": "12.59",
    "mcapval": "1,175.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE312C01025",
    "curr_date": "Jan 29",
    "curr_time": "",
    "bse_nse_vol": "20.47 lacs",
    "exc_status": "Active",
    "traded_date": "Jan 29, 2026",
    "traded_date_str": "2026 01 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syncom-formul-831770-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Syncom Formulations (India) Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-syncom-formulations-india-ltd-fallingrising-3808509",
        "imagepath": "",
        "date": "2026-01-29 00:53:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Syncom Formulations’ share price gained ₹0.68 on 28 January, outperforming its sector by 5.24%. This rebound is significant given the stock’s recent downward trajectory, marking a recovery after two days of consecutive falls. The stock’s current price sits above its 5-day moving average, indicating some immediate buying interest, although it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. This suggests that while short-term momentum is positive, the broader trend remains subdued.</p>\n<p>Liquidity conditions remain adequate, with the stock’s trading volume on 27 January recorded at 7.62 lakh shares. However, this represents a 38% decline compared to the five-day average delivery volume, signalling a drop in i..."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3801382",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_mojoScore_3801382.png",
        "date": "2026-01-23 10:10:54",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 23 January 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Syncom Formulations (India) Ltd Hits 52-Week Low at Rs.11.52",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-hits-52-week-low-at-rs1152-3800161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3800161.png",
        "date": "2026-01-22 11:01:13",
        "description": "Syncom Formulations (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.11.52 today, marking a significant decline amid broader market movements and company-specific performance trends."
      },
      {
        "title": "Syncom Formulations (India) Ltd Falls to 52-Week Low Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-amid-market-downturn-3796257",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3796257.png",
        "date": "2026-01-20 11:07:23",
        "description": "Syncom Formulations (India) Ltd has touched a new 52-week low of Rs.12.3 today, marking a significant decline in its share price amid broader market pressures and company-specific performance trends."
      },
      {
        "title": "Syncom Formulations (India) Ltd Falls to 52-Week Low Amidst Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-amidst-market-downturn-3794569",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3794569.png",
        "date": "2026-01-19 11:42:09",
        "description": "Syncom Formulations (India) Ltd’s stock touched a fresh 52-week low of Rs.12.75 today, marking a significant decline amid broader market pressures and company-specific performance trends. The stock’s fall contrasts with the broader Sensex, which remains near its yearly highs despite recent volatility."
      },
      {
        "title": "Syncom Formulations (India) Ltd Falls to 52-Week Low of Rs.12.78",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-of-rs1278-3791066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3791066.png",
        "date": "2026-01-12 13:00:19",
        "description": "Syncom Formulations (India) Ltd has touched a new 52-week low of Rs.12.78 today, marking a significant decline in its stock price amid a broader market that remains resilient. The pharmaceutical company’s shares have been under pressure, reflecting a series of challenges that have weighed on investor sentiment over the past year."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3789704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_mojoScore_3789704.png",
        "date": "2026-01-12 10:10:38",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Syncom Formulations (India) Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-amidst-continued-downtrend-3787013",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3787013.png",
        "date": "2026-01-09 10:02:28",
        "description": "Syncom Formulations (India) Ltd has reached a new 52-week low of Rs.13.23, marking a significant decline in its stock price amid a challenging year for the company. This fresh low reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, where the stock has underperformed relative to broader market indices."
      },
      {
        "title": "Syncom Formulations (India) Ltd Falls to 52-Week Low Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-amidst-continued-underperformance-3785494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SyncomFormulati_priceRelatedfactors_3785494.png",
        "date": "2026-01-08 11:17:02",
        "description": "Syncom Formulations (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.13.72 on 8 Jan 2026, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance trends."
      }
    ],
    "total": 243,
    "sid": "831770",
    "stock_news_url": "https://www.marketsmojo.com/news/syncom-formulations-india-831770"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>3%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Why is Syncom Formulations (India) Ltd falling/rising?

2026-01-29 00:53:48

Short-Term Price Movement and Market Context

Syncom Formulations’ share price gained ₹0.68 on 28 January, outperforming its sector by 5.24%. This rebound is significant given the stock’s recent downward trajectory, marking a recovery after two days of consecutive falls. The stock’s current price sits above its 5-day moving average, indicating some immediate buying interest, although it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. This suggests that while short-term momentum is positive, the broader trend remains subdued.

Liquidity conditions remain adequate, with the stock’s trading volume on 27 January recorded at 7.62 lakh shares. However, this represents a 38% decline compared to the five-day average delivery volume, signalling a drop in i...

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-01-23 10:10:54

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 23 January 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Syncom Formulations (India) Ltd Hits 52-Week Low at Rs.11.52

2026-01-22 11:01:13

Syncom Formulations (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.11.52 today, marking a significant decline amid broader market movements and company-specific performance trends.

Read full news article

Syncom Formulations (India) Ltd Falls to 52-Week Low Amid Market Downturn

2026-01-20 11:07:23

Syncom Formulations (India) Ltd has touched a new 52-week low of Rs.12.3 today, marking a significant decline in its share price amid broader market pressures and company-specific performance trends.

Read full news article

Syncom Formulations (India) Ltd Falls to 52-Week Low Amidst Market Downturn

2026-01-19 11:42:09

Syncom Formulations (India) Ltd’s stock touched a fresh 52-week low of Rs.12.75 today, marking a significant decline amid broader market pressures and company-specific performance trends. The stock’s fall contrasts with the broader Sensex, which remains near its yearly highs despite recent volatility.

Read full news article

Syncom Formulations (India) Ltd Falls to 52-Week Low of Rs.12.78

2026-01-12 13:00:19

Syncom Formulations (India) Ltd has touched a new 52-week low of Rs.12.78 today, marking a significant decline in its stock price amid a broader market that remains resilient. The pharmaceutical company’s shares have been under pressure, reflecting a series of challenges that have weighed on investor sentiment over the past year.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-01-12 10:10:38

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Syncom Formulations (India) Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-01-09 10:02:28

Syncom Formulations (India) Ltd has reached a new 52-week low of Rs.13.23, marking a significant decline in its stock price amid a challenging year for the company. This fresh low reflects ongoing pressures within the Pharmaceuticals & Biotechnology sector, where the stock has underperformed relative to broader market indices.

Read full news article

Syncom Formulations (India) Ltd Falls to 52-Week Low Amidst Continued Underperformance

2026-01-08 11:17:02

Syncom Formulations (India) Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.13.72 on 8 Jan 2026, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance trends.

Read full news article

View All News